Evidence map›Paper›PMID 40637873›Full record

ArticleImmunogenetics2025

Full-length gene polymorphism of the non-classical HLA-E in Estonian individuals.

Timo I Olieslagers, Ingrid Tagen, Mathijs Groeneweg, Marcel G J Tilanus, Lotte Wieten, Christina E M Voorter

Abstract read
In one paragraph

Article in Immunogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Timo I OlieslagersMaastricht University Medical Center+, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands. timo.olieslagers@mumc.nl.
Ingrid TagenUnited Laboratories, Tartu University Hospitals, Tartu, Estonia.
Mathijs GroenewegMaastricht University Medical Center+, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.
Marcel G J TilanusMaastricht University Medical Center+, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.
Lotte WietenMaastricht University Medical Center+, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.
Christina E M VoorterMaastricht University Medical Center+, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estonia is a small country in the Baltic region of Northern Europe with 1.3 million inhabitants. As a coastal area, the population of Estonia was subjected to migration influences. Due to this admixture of populations, HLA gene diversity in Estonia is interesting to study with regard to allele frequencies, haplotypes, and polymorphism. In this study, we focused on HLA-E polymorphism within the Estonian population and compared these with the polymorphism identified in other populations. Full-length HLA-E sequencing of 143 individuals originating from Estonia show dimorphism frequencies at amino acid position 107 (0.55 R vs 0.45 G) comparable to other populations. Within the study population, 16 different HLA-E alleles were identified, including four novel alleles. These 16 alleles encode four different protein variants. Despite a strong differentiation between the South-East and the rest of the Estonian country, no allele frequency differences for HLA-E between these regions were identified. Comparing the allele and SNP frequencies to frequencies found in the different neighboring countries revealed no major differences, except for the SNP encoding for HLA-E*01:06. Association analysis between classical HLA class I genes and polymorphism at amino acid position 107 of HLA-E revealed higher frequencies of HLA-A*01 with R107 and HLA-A*03 and HLA-C*04 with G107. In summary, our study provides new insights into HLA-E variation within the Estonian population and demonstrates that its level of polymorphism is comparable to those observed in other global populations.

Indexed as

Histocompatibility Antigens Class IAllelesEstoniaFemaleGene FrequencyGenetics, PopulationHaplotypesHLA-E AntigensHumansMalePolymorphism, GeneticPolymorphism, Single NucleotideHistocompatibility Antigens Class IHLA-E AntigensAllele frequencyEstoniaHLA-EPopulation diversitySequencing

Identifiers

PMID40637873
PMCPMC12245991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.